Pharmacology & ToxicologyFrontiers in PharmacologyPeer-reviewed
The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice
Xin-Jun Wu, Karen A. Oppelt, Ming Fan…·Li V. Yang
This study shows that the GPR4 antagonist NE-52-QQ57 improves survival, reduces inflammation, and lowers viral load in SARS-CoV-2-infected mice.
2 citations